OTERO-LOSADA M; GUBELLINI, PAOLO; CAPANI F; PEREZ-LLORET, SANTIAGO

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II

Frontiers in Pharmacology; Lugar: Laussane; Año: 2023

MYLIUS, V.; PEREZ LLORET, S.; BROOK, C. S.; KRÜGER, M. T.; HÄGELE-LINK, S.; GONZENBACH, R.; KASSUBEK, J.; BOHLHALTER, S.; LEFAUCHEUR, J. P.; TIMMERMANN, L.; KÄGI, G.; BRUGGER, F.; CIAMPI DE ANDRADE, D.; MÖLLER, J. C.

Die neue Parkinson-Schmerzklassifikation (PSK)

NERVENARZT; Lugar: Berlin; Año: 2022

GEORGES, CLAIRE; LLORET-PEREZ, SANTIAGO; ORY-MAGNE, FABIENNE; FABBRI, MARGHERITA; FOUBERT-SAMIER, ALEXANDRA; MEISSNER, WASSILIOS G.; RASCOL, OLIVIER; PAVY-LE TRAON, ANNE

Alterations in electrochemical skin conductance as a marker of autonomic dysfunction in multiple system atrophy

PARKINSONISM & RELATED DISORDERS; Año: 2022 vol. 103 p. 56 - 59

OTERO-LOSADA, MATILDE; PETROVSKY, NIKOLAI; ALAMI, ABDALLAH; CRISPO, JAMES A.; MATTISON, DONALD; CAPANI, FRANCISCO; GOETZ, CHRISTOPHER; KREWSKI, DANIEL; PEREZ-LLORET, SANTIAGO

Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom

EXPERT OPINION ON DRUG SAFETY; Año: 2022

MYLIUS V; MAES L; NEGELE K; SCHMID C; SYLVESTER R; BROOK CS; BRUGGER F; PEREZ-LLORET, SANTIAGO; BANSI J; AMINIAN K; PARISCHIV AI; GOZENBACH R; BRUGGER P

Dual-Task Treadmill Training for the Prevention of Falls in Parkinson's Disease: Rationale and Study Design

Frontiers in Rehabilitation Sciences; Lugar: Laussane; Año: 2022

LOUREIRO, DÉBORA; BILBAO, RODRIGO; BORDET, SOFÍA; GRASSO, LINA; OTERO-LOSADA, MATILDE; CAPANI, FRANCISCO; PONZO, OSVALDO J.; PEREZ-LLORET, SANTIAGO

A systematic review and meta-analysis on the association between orthostatic hypotension and mild cognitive impairment and dementia in Parkinson’s disease

NEUROLOGICAL SCIENCES; Año: 2022

MYLIUS, VEIT; PEREZ LLORET, SANTIAGO; CIAMPI DE ANDRADE, DANIEL

On the diagnosis of pain in Parkinson disease: a mechanism-based approach

PAIN; Lugar: Amsterdam; Año: 2022 vol. 163 p. 495 - 495

ALAMI, ABDALLAH; KREWSKI, DANIEL; MATTISON, DONALD; WILSON, KUMANAN; GRAVEL, CHRISTOPHER A.; VILLENEUVE, PAUL J.; FARRELL, PATRICK J.; CRISPO, JAMES A. G.; PEREZ-LLORET, SANTIAGO

Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations

Vaccines; Lugar: Amsterdam; Año: 2022 vol. 10

OTERO-LOSADA, MATILDE; GUBELLINI, PAOLO; CAPANI, FRANCISCO; PEREZ-LLORET, SANTIAGO

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease

Frontiers in Pharmacology; Lugar: Laussane; Año: 2021 vol. 12

PEREZ-LLORET, SANTIAGO; VAN DE WARRENBURG, BART; ROSSI, MALCO; RODRÍGUEZ-BLÁZQUEZ, CARMEN; ZESIEWICZ, THERESA; SAUTE, JONAS A.M.; DURR, ALEXANDRA; NISHIZAWA, MASATOYO; MARTINEZ-MARTIN, PABLO; STEBBINS, GLENN T.; SCHRAG, ANETTE; SKORVANEK, MATEJ; BROWN, RICHARD G; GOLDMAN, JENNIFER G; DE SIQUEIRA TOSIN, MICHELLE HYCZY; SHUKLA, APARNA WAGLE; VIOLANTE, MAYELA RODRIGUEZ; WEINTRAUB, DANIEL

Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations

MOVEMENT DISORDERS; Año: 2021 vol. 36 p. 283 - 297

SZYLD, EDGARDO G.; AGUILAR, ADRIANA; LLORET, SANTIAGO PEREZ; PARDO, AMORINA; FABRES, JORGE; CASTRO, ADRIANA; DANNAWAY, DOUGLAS; DESAI, PURNAHAMSI V.; CAPELLI, CAROLA; SONG, CLARA H.; ENRIQUEZ, DIEGO; SZYLD, DEMIAN

Self-directed video versus instructor-based neonatal resuscitation training: a randomized controlled blinded non-inferiority multicenter international study

JOURNAL OF PERINATOLOGY; Año: 2021

GUSTAVO LOPARDO; WALDO BELLOSO; ESTEBAN NANINNI; MARIANA COLONNA; SANTIAGO SANGUINETTI; VANESA ZYLBERMAN; LUCIANA MUÑOZ; SANTIAGO PEREZ LLORET; LINUS SPATZ; FERNANDO GOLDBAUM

RBD-specific polyclonal F(ab´) 2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial

EClinicalMedicine; Año: 2021

MYLIUS, VEIT; MÖLLER, JENS CARSTEN; BOHLHALTER, STEPHAN; CIAMPI DE ANDRADE, DANIEL; PEREZ LLORET, SANTIAGO

Diagnosis and Management of Pain in Parkinson's Disease: A New Approach

DRUGS AND AGING; Año: 2021 vol. 38 p. 559 - 577

UDOVIN, LUCAS; OTERO-LOSADA, MATILDE; BORDET, SOFIA; CHEVALIER, GUENSON; QUARRACINO, CECILIA; CAPANI, FRANCISCO; PÉREZ-LLORET, SANTIAGO

Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database

PARKINSONISM & RELATED DISORDERS; Año: 2021 vol. 86 p. 34 - 37

KOBIEC, TAMARA; OTERO-LOSADA, MATILDE; CHEVALIER, GUENSON; UDOVIN, LUCAS; BORDET, SOFÍA; MENÉNDEZ-MAISSONAVE, CAMILA; CAPANI, FRANCISCO; PÉREZ-LLORET, SANTIAGO

The Renin-Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene

Frontiers in Synaptic Neuroscience; Lugar: Laussane; Año: 2021 vol. 13

VAN WAMELEN, DANIEL J.; SAUERBIER, ANNA; LETA, VALENTINA; RODRIGUEZ-BLAZQUEZ, CARMEN; FALUP-PECURARIU, CRISTIAN; RODRIGUEZ?VIOLANTE, MAYELA; RIZOS, ALEXANDRA; TSUBOI, Y.; METTA, VINOD; BHIDAYASIRI, ROONGROJ; BHATTACHARYA, KALYAN; BORGOHAIN, RUPAM; PRASHANTH, L.K.; ROSALES, RAYMOND; LEWIS, SIMON; FUNG, VICTOR; BEHARI, MADHURI; GOYAL, VINAY; KISHORE, ASHA; LLORET, SANTIAGO PEREZ; MARTINEZ-MARTIN, PABLO; CHAUDHURI, K. RAY

Cross-sectional analysis of the Parkinson's disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life

Scientific Reports; Lugar: Londres; Año: 2021 vol. 11

PEREZ-LLORET, SANTIAGO; DANIEL CARDINALI

Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease

Frontiers in Pharmacology; Lugar: Laussane; Año: 2021

OLIVIER RASCOL; VALERIA COCHEN; ANNE PAVY; ALEXANDRA FOUBERT; CLAIRE THALAMAS; AGNES SOMMET; VANESSA ROUSSEAU; PEREZ LLORET, SANTIAGO; FABBRI, MARGHERITA; JEAN PHILIPPE AZULAY; JEAN-CHRISTOPH CORVOL; PHILIPPE COURATIER; PHILIPPE DAMIER; LUC DEFEBVRE; FRANCK DURIFF; CHRISTIAN GENY; JEAN-LUC HOUETO; PHILIPPE REMY; CHRISTINE TRANCHANT; MARC VERIN; FRANCOIS TISON; MEISSNER, WASSILIOS G.

Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial

MOVEMENT DISORDERS; Lugar: New York; Año: 2021

OTERO-LOSADA, MATILDE; GUBELLINI, PAOLO; CAPANI, FRANCISCO; PEREZ-LLORET, SANTIAGO

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease

Frontiers in Pharmacology; Año: 2021 vol. 12

ROSSI, MALCO; PEREZ-LLORET, SANTIAGO; MERELLO, MARCELO

How much time is needed in clinical practice to reach a diagnosis of clinically established Parkinson's disease?

PARKINSONISM & RELATED DISORDERS; Año: 2021 vol. 92 p. 53 - 58

RUMMEY, CHRISTIAN; ZESIEWICZ, THERESA A.; PEREZ-LLORET, SANTIAGO; FARMER, JENNIFER M.; PANDOLFO, MASSIMO; LYNCH, DAVID R.

Test–retest reliability of the Friedreich’s ataxia rating scale

Annals of Clinical and Translational Neurology; Año: 2020 vol. 7 p. 1708 - 1712

OTERO-LOSADA, MATILDE; KOBIEC, TAMARA; UDOVIN, LUCAS; CHEVALIER, GUENSON; QUARRACINO, CECILIA; MENÉNDEZ MAISSONAVE, CAMILA; BORDET, SOFIA; CAPANI, FRANCISCO; PEREZ-LLORET, SANTIAGO

Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic

Frontiers in Neurology; Año: 2020 vol. 11

RASCOL, OLIVIER; NEGRE-PAGES, LAURENCE; DAMIER, PHILIPPE; DELVAL, ARNAUD; DERKINDEREN, PASCAL; DESTÉE, ALAIN; FABBRI, MARGHERITA; MEISSNER, WASSILIOS G.; RACHDI, AMINE; TISON, FRANÇOIS; PEREZ-LLORET, SANTIAGO

Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort

JOURNAL OF NEURAL TRANSMISSION. GENERAL SECTION.; Año: 2020 vol. 127 p. 1607 - 1617

SEOANE, HERNAN A.; MOSCHETTO, LEANDRA; ORLIACQ, FRANCISCO; ORLIACQ, JOSEFINA; SERRANO, EZEQUIEL; CAZENAVE, MARÍA INÉS; VIGO, DANIEL E.; PEREZ-LLORET, SANTIAGO

Sleep disruption in medicine students and its relationship with impaired academic performance: A systematic review and meta-analysis

SLEEP MEDICINE REVIEWS; Año: 2020 vol. 53

BRIL, ANDREA; PEREZ-LLORET, SANTIAGO; ROSSI, MALCO; FARIÑA, SOFÍA; MORISSET, PIERRE; SORRENTINO, LAURA; IGLESIAS, MICAELA; MEDINA ESCOBAR, ALEX; MILLAR VERNETTI, PATRICIO; CERQUETTI, DANIEL; MERELLO, MARCELO

A multifactorial study on nutritional status, binge eating and physical activity as main factors directly influencing body weight in Parkinson’s disease

npj Parkinson's Disease; Año: 2020 vol. 3

UDOVIN, LUCAS; QUARRACINO, CECILIA; HERRERA, MARÍA I.; CAPANI, FRANCISCO; OTERO-LOSADA, MATILDE; PEREZ-LLORET, SANTIAGO

Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson’s Disease Animal Models from a Molecular Signaling Perspective

Neural Plasticity; Lugar: London; Año: 2020 vol. 2020 p. 1 - 10

RASCOL, OLIVIER; NEGRE-PAGES, LAURENCE; DAMIER, PHILIPPE; DELVAL, ARNAUD; DERKINDEREN, PASCAL; DESTÉE, ALAIN; FABBRI, MARGHERITA; MEISSNER, WASSILIOS G.; RACHDI, AMINE; TISON, FRANÇOIS; PEREZ-LLORET, SANTIAGO

Utilization Patterns of Amantadine in Parkinson’s Disease Patients Enrolled in the French COPARK Study

DRUGS AND AGING; Lugar: Berlín; Año: 2020 vol. 37 p. 215 - 223

QUARRACINO, CECILIA; OTERO-LOSADA, MATILDE; CAPANI, FRANCISCO; PÉREZ-LLORET, SANTIAGO

State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson’s disease

EXPERT OPINION ON PHARMACOTHERAPY; Año: 2020 vol. 21 p. 445 - 457

QUARRACINO, CECILIA; OTERO-LOSADA, MATILDE; CAPANI, FRANCISCO; PÉREZ-LLORET, SANTIAGO

Prevalence and factors related to orthostatic syndromes in recently diagnosed, drug-naïve patients with Parkinson disease

CLINICAL AUTONOMIC RESEARCH; Año: 2020 vol. 30 p. 265 - 271

FABBRI, MARGHERITA; PEREZ-LLORET, SANTIAGO; RASCOL, OLIVIER

Therapeutic strategies for Parkinson’s disease: promising agents in early clinical development

EXPERT OPINION ON INVESTIGATIONAL DRUGS; Año: 2020 vol. 29 p. 1249 - 1267

PEREZ LLORET, SANTIAGO (COMPARTE 1ERA POSICIÓN CON MYLIUS, VEIT); MYLIUS, VEIT; CURY, RUBENS G.; TEIXEIRA, MANOEL J.; BARBOSA, VICTOR R.; BARBOSA, EGBERTO R.; MOREIRA, LARISSA I.; LISTIK, CLARICE; FERNANDES, ANA M.; DE LACERDA VEIGA, DIOGO; BARBOUR, JULIO; HOLLENSTEIN, NATHALIE; OECHSNER, MATTHIAS; WALCH, JULIA; BRUGGER, FLORIAN; HÄGELE-LINK, STEFAN; BEER, SERAFIN; RIZOS, ALEXANDRA; CHAUDHURI, KALLOL RAY; BOUHASSIRA, DIDIER; LEFAUCHEUR, JEAN-PASCAL; TIMMERMANN, LARS; GONZENBACH, ROMAN; KÄGI, GEORG; MÖLLER, JENS CARSTEN; CIAMPI DE ANDRADE, DANIEL

The Parkinson's disease pain classification system (PDPCS): results from an international mechanism-based classification approach

PAIN; Lugar: Amsterdam; Año: 2020

HERRERA, MARÍA INÉS; KÖLLIKER-FRERS, RODOLFO ALBERTO; OTERO-LOSADA, MATILDE; PEREZ LLORET, SANTIAGO; FILIPPO, MACARENA; TAU, JULIA; CAPANI, FRANCISCO; VILLA, ANDRÉS M.

A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis

Frontiers in Neurology; Lugar: Amsterdam; Año: 2019 vol. 10 p. 1 - 1

SEPPI, KLAUS; RAY CHAUDHURI, K.; COELHO, MIGUEL; FOX, SUSAN H.; KATZENSCHLAGER, REGINA; PEREZ LLORET, SANTIAGO; WEINTRAUB, DANIEL; SAMPAIO, CRISTINA

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

MOVEMENT DISORDERS; Lugar: New York; Año: 2019 vol. 34 p. 180 - 198

PÉREZ-LLORET, SANTIAGO; QUARRACINO, CECILIA; OTERO-LOSADA, MATILDE; RASCOL, OLIVIER

Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases

EXPERT OPINION ON PHARMACOTHERAPY; Año: 2019 vol. 20 p. 635 - 645

MATTA, M.; PAVY-LE TRAON, A.; PEREZ-LLORET, S.; LAPORTE, C.; BERDUGO, I.; NASR, N.; HANAIRE, H.; SENARD, J. M.

Predictors of Cardiovascular Autonomic Neuropathy Onset and Progression in a Cohort of Type 1 Diabetic Patients

Journal of Diabetes Research; Año: 2018 vol. 2018 p. 1 - 8

PEREZ-LLORET, SANTIAGO; RASCOL, OLIVIER

Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia

JOURNAL OF NEURAL TRANSMISSION. GENERAL SECTION.; Año: 2018

REY, MARÍA VERÓNICA; MOLINA, LUIS; RECINOS, BYRON; PAZ, BEZNER; ROVELO, MAURICIO; RODRIGUEZ ELIAS, FANNY ELIZABETH; CALDERÓN, JOSÉ; ARELLANO, ARTURO; PEREZ-LLORET, SANTIAGO

Movement Disorders after Exposure to Antipsychotic Drugs in Patients with Depressive Disorders

CLINICAL NEUROPHARMACOLOGY; Año: 2018 vol. 41 p. 177 - 180

PEREZ-LLORET, S.; NEGRE-PAGES, L.; DAMIER, P.; DELVAL, A.; DERKINDEREN, P.; DESTÉE, A.; MEISSNER, W. G.; TISON, F.; RASCOL, O.

L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey

EUROPEAN JOURNAL OF NEUROLOGY; Año: 2017 vol. 24 p. 1532 - 1538

PEREZ-LLORET, SANTIAGO; OTERO-LOSADA, MATILDE; TOBLLI, JORGE E.; CAPANI, FRANCISCO

Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease

EXPERT OPINION ON INVESTIGATIONAL DRUGS; Año: 2017 vol. 26 p. 1163 - 1173

ALEXANDRA FOUBERT-SAMIER; MIGUEL VAGO; SEBASTIAN PEREZ; MARCELO RUBIO; CECILIA GONZALEZ; CRISTIAN MAGARIÑOS; MONICA ROSEMBERG; FERNANDO COSTA; PEREZ LLORET, SANTIAGO

A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m 2 (Dralitem vs. Temodal Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions

Drugs in R&D; Lugar: Amsterdam; Año: 2017

SANTIAGO PÉREZ LLORET; OLIVIER RASCOL

The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease.

Expert Review of Neurotherpautics; Lugar: Londres; Año: 2016 vol. 16 p. 245 - 258

SANTIAGO PÉREZ LLORET; OLIVIER RASCOL

Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.

CNS DRUGS; Año: 2016 vol. 30 p. 703 - 717

JAMES CRISPO; ALICE WILLIS; DP THIBAULT; YANNICK FORTIN; HAYS HD; MCNAIR MC; BJERRE LM; KOHEN DE; SANTIAGO PÉREZ LLORET; DAVID MATTISON; DANIEL KREWSKI

Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.

PLOS ONE; Lugar: San Francisco; Año: 2016 vol. 11 p. 21 - 28

CURY RG; GALHARDONI R; FONOFF ET; SANTAIGO PEREZ-LLORET; DOS SANTOS MG; BARBOSA ER; TEXEIRA MG; CIAMPI DE ANDRADE

Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms.

EUROPEAN JOURNAL OF PAIN; Lugar: Amsterdam; Año: 2016 vol. 20 p. 151 - 165

PATRICIO MILLAR VERNETTI; MALCO ROSSI; DANIEL CERQUETTI; SANTIAGO PÉREZ LLORET; MARCELO MERELLO

Comparison of Olfactory Identification Patterns among Parkinson's Disease Patients from Different Countries.

CHEMICAL SENSES; Lugar: Oxford; Año: 2016 vol. 41 p. 77 - 83

SANTIAGO PÉREZ LLORET

Investigational drugs for autonomic dysfunction in Parkinson's disease.

EXPERT OPINION ON INVESTIGATIONAL DRUGS; Lugar: London; Año: 2016 vol. 25 p. 259 - 262

MOLINA L; RECINOS B; ROVELO M; ELIAS RODRIGUEZ; CALDERON J; ARELLANO A; POMATA S; MARIA VERÓNICA REY; SANTIAGO PÉREZ LLORET

Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study.

CLINICAL DRUG INVESTIGATION; Lugar: Sydney; Año: 2016 vol. 36 p. 491 - 497

PEREZ-LLORET, SANTIAGO; PERALTA, MARÍA CECILIA; BARRANTES, FRANCISCO J.

Pharmacotherapies for Parkinson’s disease symptoms related to cholinergic degeneration

EXPERT OPINION ON PHARMACOTHERAPY; Año: 2016 vol. 17 p. 2405 - 2415

NEAL FARBER; SANTIAGO PÉREZ LLORET; ELKAN GAMZU

Design and development of a novel supportive care product for the treatment of sialorrhea in Parkinson's disease

Current Topics in Medicinal Chemistry; Lugar: Oak Park; Año: 2015 vol. 15 p. 939 - 954

MALCO ROSSI; MARCELO MERELLO; SANTIAGO PEREZ LLORET

Management of constipation in Parkinson's disease

EXPERT OPINION ON PHARMACOTHERAPY; Lugar: London; Año: 2015 vol. 16 p. 547 - 557

OLIVIER RASCOL; SANTIAGO PÉREZ LLORET; JOAQUIM FERREIRA

New treatments for levodopa-induced motor complications.

MOVEMENT DISORDERS; Lugar: New York; Año: 2015 vol. 30 p. 1451 - 1460

LUCA RATTI; LAURENCE NEGRE-PAGES; SANTIAGO PÉREZ LLORET; MANNI R; PHILIPPE DAMIER; FRANCOIS TISON; ALAIN DESTEE; OLIVIER RASCOL

Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort.

PARKINSONISM & RELATED DISORDERS; Lugar: Amsterdam; Año: 2015 vol. 21 p. 1323 - 1329

MALCO ROSSI; SANTIAGO PÉREZ LLORET; PATRICIO MILLAR VERNETTI; LUCAS DRUCAROFF; E CONSTANZO; DIEGO BALLESTEROS; ANDREA BRIL; DANIEL CERQUETTI; SALVADOR GUINJOAN; MARCELO MERELLO

Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease.

MOVEMENT DISORDERS; Lugar: New York; Año: 2015

JAMES CRISPO; YANNICK FORTIN; DP THIBAULT; M EMONS; LM BJERRE; DE KOHEN; SANTIAGO PEREZ LLORET; DAVID MATTISON; ALICE WILLIS; DANIEL KREWSKI

Trends in inpatient antiparkinson drug use in the USA, 2001-2012

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY; Lugar: Berlin; Año: 2015

A. PAVY-LE TRAON; A PIEDVACHE; SANTIAGO PÉREZ LLORET; CALANDRA-BUONARA; VALERIE COCHEN; CARLO COLOSIMO; P CORTELLI; RACHEL DEBS; DUERR S; A FIANCULLI; ALEXANDRA FOUBERT-SAMIER; ANGELA GARDELAT; T GUREVICH; F KRISMER; WERNER POEWE; FRANCOIS TISON; C TRANCHANT; GREGOR WENNING; WASSILIOS MEISSNER; OLIVIER RASCOL

New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study

JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY; Lugar: Londres; Año: 2015

OLIVIER RASCOL; SANTIAGO P¨¦REZ LLORET; PHILIPPE DAMIER; ANTOINE DELVAL; PAUL DERKINDEREN; ALAIN DESTEE; WASSILIOS MEISSNER; FRANCOIS TISON; LAURENCE NEGRE-PAGES

Falls in ambulatory non-demented patients with Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT; Lugar: Berlin; Año: 2015

SANTIAGO PÉREZ LLORET; MARIA VERÓNICA REY; JAMES CRISPO; DANIEL KREWSKI; MARISE LAPEYRE-MESTRE; JEAN-LOUIS MONTASTRUC; OLIVIER RASCOL

Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients

EXPERT OPINION ON DRUG SAFETY; Lugar: London; Año: 2014 vol. 13 p. 351 - 360

MALCO ROSSI; SANTIAGO PÉREZ LLORET; LILIANA DOLDAN; DANIEL CERQUETTI; JORGE BALEJ; PATRICIO MILLAR VERNETTI; MARTIN HAWKES; ANGEL CAMMAROTA; MARCELO MERELLO

Autosomal dominant cerebellar ataxias: a systematic review of clinical features

EUROPEAN JOURNAL OF NEUROLOGY; Lugar: Londres; Año: 2014 vol. 21 p. 607 - 615

SANTIAGO PÉREZ LLORET; JOAQUIN DIEZ; MN DOMÉ; AA DELVENNE; NESTOR BRAIDOT; DANIEL CARDINALI; DANIEL VIGO

Effects of different "relaxing" music styles on the autonomic nervous system

NOISE AND HEALTH; Lugar: London; Año: 2014 vol. 16 p. 279 - 284

SANTIAGO PÉREZ LLORET; LAURENCE NEGRE-PAGES; PHILIPPE DAMIER; ANTOINE DELVAL; PAUL DERKINDEREN; ALAIN DESTEE; WASSILIOS MEISSNER; LUDGIW SCHELOWSKY; FRANCOIS TISON; OLIVIER RASCOL

Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease

JAMA Neurology; Lugar: New York; Año: 2014 vol. 71 p. 884 - 890

MALCO ROSSI; SANTIAGO PÉREZ LLORET; LUCIA DOLDAN; DANIEL CERQUETTI; JORGE BALEJ; PATRICIO MILLAR VERNETTI; H HAWKES; ANGEL CAMMAROTA; MARCELO MERELLO

Autosomal dominant cerebellar ataxias: a systematic review of clinical features

EUROPEAN JOURNAL OF NEUROLOGY; Lugar: Londres; Año: 2014 vol. 21 p. 607 - 615

MARIA VERÓNICA REY; SANTIAGO PÉREZ LLORET; ANNE PAVY; WASSILIOS MEISSNER; FRANCOIS TISON; OLIVIER RASCOL

A cross-sectional study on drug use in multiple system atrophy

CNS DRUGS; Lugar: Sydney; Año: 2014 vol. 28 p. 483 - 490

SANTIAGO PEREZ LLORET; MARCELO MERELLO

Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline vs tozadenant

EXPERT OPINION ON PHARMACOTHERAPY; Lugar: London; Año: 2014

MARIA VERÓNICA REY; SANTIAGO PEREZ LLORET; ANNE PAVY; WASSILIOS MEISSNER; FRANCOIS TISON; OLIVIER RASCOL

A cross-sectional study on Drug Utilization in Multiple System Atrophy

CNS DRUGS; Año: 2014

SANTIAGO PEREZ LLORET; MARIA VERÓNICA REY; ANNE PAVY; OLIVIER RASCOL

Emerging drugs for autonomic dysfunction in Parkinson's disease

EXPERT OPINION ON EMERGING DRUGS; Lugar: London; Año: 2013 vol. 18 p. 39 - 53

SANTIAGO PÉREZ LLORET; ALEJANDRO J. VIDELA; ALBA RICHADEAU; DANIEL E. VIGO; MALCO ROSSI; DANIEL P. CARDINALI; DANIEL PEREZ-CHADA

A multi-step pathway connecting short sleep duration to daytime somnolence, reduced attention, and poor academic performance: an exploratory cross-sectional study in teenagers.

JOURNAL OF CLINICAL SLEEP MEDICINE; Lugar: Nueva York; Año: 2013 vol. 9 p. 469 - 473

SANTIAGO PEREZ LLORET

Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease: an old drug revisited

EUROPEAN JOURNAL OF NEUROLOGY; Lugar: Londres; Año: 2013 vol. 20 p. 1427 - 1428

SANTIAGO PÉREZ LLORET; MARIA VERÓNICA REY; ANNE PAVY; OLIVIER RASCOL

Droxidopa for the treatment of neurogenic orthostatic hypotension and other symptoms of neurodegenerative disorders

Expert Opinion in Orphan Drugs; Año: 2013

SOLERNO JI; DANIEL PEREZ-CHADA; GUINJOAN SR; SANTIAGO PÉREZ LLORET; HEDDERWICK A; VIDAL MF; DANIEL CARDINALI; DANIEL E. VIGO

Cardiac autonomic activity predicts dominance in verbal over spatial reasoning tasks: results from a preliminary study.

AUTONOMIC NEUROSCIENCE.; Lugar: Amsterdam; Año: 2012 vol. 167 p. 78 - 80

SANTIAGO PÉREZ LLORET; ROJAS GM; MENONI MC; RUIZ G; VELÁSQUEZ C; RODRIGUEZ H, ; MARIA VERÓNICA REY; DANIEL CARDINALI

Pregabalin beneficial effects on sleep quality or health-related quality of life are poorly correlated with reduction on pain intensity after an 8-week treatment course.

CLINICAL NEUROPHARMACOLOGY; Lugar: Philadelphia; Año: 2012 vol. 35 p. 21 - 24

SANTIAGO P¨¦REZ LLORET; MARIA VER¨®NICA REY; FABRE N; FABIENNE ORY-MAGNE; UMBERTO SPAMPINATO; JEAN-LOUIS MONTASTRUC; OLIVIER RASCOL

Do Parkinson's disease patients disclose their adverse events spontaneously?

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY; Lugar: Berlin; Año: 2012 vol. 68 p. 857 - 865

MILLAR VERNETTI P; SANTIAGO PÉREZ LLORET; ROSSI M; CERQUETTI D; MARCELO MERELLO

Validation of a new scale to assess olfactory dysfunction in patients with Parkinson's disease.

PARKINSONISM & RELATED DISORDERS; Lugar: Amsterdam; Año: 2012 vol. 18 p. 358 - 361

SANTIAGO PÉREZ LLORET; MARIA VERÓNICA REY; LUCA RATTI; OLIVIER RASCOL

Rotigotine transdermal patch for the treatment of Parkinson's Disease.

FUNDAM. CLIN. PHARMACOL.; Lugar: Londres; Año: 2012 p. 1 - 28

SANTIAGO P¨¦REZ LLORET; MARIA VER¨®NICA REY; NELLY FABRE; FABIENNE ORY-MAGNE; UMBERTO SPAMPINATO; SENARD JM; PAVY A; JEAN-LOUIS MONTASTRUC; OLIVIER RASCOL

Factors related to orthostatic hypotension in Parkinson's disease.

PARKINSONISM & RELATED DISORDERS; Lugar: Amsterdam; Año: 2012 vol. 18 p. 501 - 505

SANTIAGO PEREZ LLORET; MARIA VERÓNICA REY; DELLAPINA E; PELLAPRAT J; BREFEL-COURBON C; RASCOL O

Emerging analgesic drugs for Parkinson's disease.

EXPERT OPINION ON EMERGING DRUGS; Lugar: London; Año: 2012 vol. 17 p. 157 - 171

SANTIAGO PÉREZ LLORET; OLIVIER RASCOL

Parkinson disease: Serotonin reuptake inhibitors for depression in PD.

NATURE REVIEWS NEUROLOGY; Lugar: Londres; Año: 2012 vol. 8 p. 365 - 366

SANTIAGO PÉREZ LLORET; OLMOS L; DE MENA F; PIECZANSKI P; RODRIGUEZ MONCALVO JJ

Bioequivalence of Lamotrigine 50-mg Tablets in Healthy Male Volunteers: a Randomized, Single-Dose, 2-Period, 2-Sequence Crossover Study.

ARZNEIMITTEL FORSCHUNG DRUG RESEARCH; Año: 2012 p. 1 - 11

SANTIAGO PEREZ LLORET; MARIA VERÓNICA REY; NELLY FABRE; FABIENNE ORY-MAGNE; UMBERTO SPAMPINATO; CHRISTINE BREFEL-COURBON; JEAN-LOUIS MONTASTRUC; OLIVIER RASCOL

Prevalence and Pharmacological Factors Associated With Impulse-Control Disorder Symptoms in Patients With Parkinson Disease

CLINICAL NEUROPHARMACOLOGY; Lugar: Philadelphia; Año: 2012 vol. 35 p. 261 - 265

SANTIAGO PEREZ LLORET; MARIA VERÓNICA REY; EMMANUELLE BONDON-GUITTON; OLIVIER RASCOL; JEAN-LOUIS MONTASTRUC

Drugs Associated With Restless Legs Syndrome: A Case/Noncase Study in the French Pharmacovigilance Database

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY; Lugar: Philadelphia; Año: 2012 vol. 32 p. 824 - 827

SANTIAGO PEREZ-LLORET; OLIVIER RASCOL

Safety of rasagiline for the treatment of Parkinson's disease.

EXPERT OPINION ON DRUG SAFETY; Año: 2011 p. 1 - 11

SANTIAGO PEREZ-LLORET; LAURENCE NEGRE-PAGES; ANA OJERO; PHILIPPE DAMIER; ALAIN DESTEE; MARCELO MERELLO; OLIVIER RASCOL

Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort.

EUROPEAN JOURNAL OF NEUROLOGY; Año: 2011 p. 1 - 10

SANTIAGO PEREZ-LLORET; MALCO ROSSI; MARCELO MERELLO; DANIEL CARDINALI

Non-motor symptoms groups in Parkinson’s Disease patients. Results of a pilot, exploratory study.

Parkinson's Disease; Año: 2011

OLIVIER RASCOL; JOAQUIM FERREIRA; LAURENCE NEGRE-PAGES; SANTIAGO PEREZ-LLORET; LUCETTE LACOMBLEZ; MONIQUE GALITZKY; JC LEMARIÉ; JC CORVOL; JONATHAN BROTCHIE; LAURA BOSSI

A proof-of-concept randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson’s disease.

FUNDAM. CLIN. PHARMACOL.; Año: 2011 p. 1 - 15

SANTIAGO PÉREZ LLORET; GABRIELA NANO; ANDREA CARROSELLA; ELKAN GAMZU; MARCELO MERELLO

A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients.

JOURNAL OF THE NEUROLOGICAL SCIENCES; Lugar: Amsterdam; Año: 2011 vol. 15 p. 248 - 250

EMMANUELLE BONDON-GUITTON; SANTIAGO PÉREZ LLORET; HALEH BAGHERI; CHRISTINE BREFEL; OLIVIER RASCOL; JEAN-LOUIS MONTASTRUC

Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France.

MOVEMENT DISORDERS; Lugar: New York; Año: 2011 vol. 26 p. 2226 - 2231

DIEZ JJ; DANIEL E. VIGO; SANTIAGO PÉREZ LLORET; RIGTERS S; ROLE N; CARDINALI DP; DANIEL PEREZ-CHADA

Sleep habits, alertness, cortisol levels, and cardiac autonomic activity in short-distance bus drivers: differences between morning and afternoon shifts.

JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE / AMERICAN COLLEGE OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE.; Lugar: Philadelphia; Año: 2011 vol. 53 p. 806 - 811

SANTIAGO PÉREZ LLORET; MARIA VERÓNICA REY; LUCA RATTI; OLIVIER RASCOL

Pramipexole for the treatment of early Parkinson's disease.

Expert review of neurotherapeutics; Lugar: Londres; Año: 2011 vol. 11 p. 925 - 935

SEPPI K; WEINTRAUB D; COEHLO M; SANTIAGO PéREZ LLORET; FOX SH; KATZENSCHLAGER R; HAMETNER EM; POEWE W; OLIVIER RASCOL; GOETZ CG; SAMPAIO C

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

MOVEMENT DISORDERS; Lugar: New York; Año: 2011 vol. 26 p. 42 - 80

SANTIAGO PEREZ-LLORET; JORGE TOBLLI; DANIEL CARDINALI; JOSÉ MILEI

Gender differences in age-related increase of asleep blood pressure.

ARCHIVES OF GERONTOLOGY AND GERIATRICS; Año: 2010 vol. 50 p. 319 - 322

MALCO ROSSI; ELIANA ROLDÁN GERSCOVICH; DELFINA DE ACHAVAL; SANTIAGO PEREZ-LLORET; DANIEL CERQUETTI; ANGEL CAMMAROTA; MARÍA INÉS NOUZEILLES; RAUL FAHRER; MARCELO MERELLO; RAMÓN LEIGUARDA

Decision-making in Parkinson's disease patients with and without pathological gambling.

EUROPEAN JOURNAL OF NEUROLOGY; Año: 2010 vol. 17 p. 97 - 102

SANTIAGO PEREZ-LLORET; MALCO ROSSI; DANIEL P. CARDINALI; MARCELO MERELLO

Activity-rest rhythm abnormalities in Parkinson's disease patients are related to dopaminergic therapy.

THE INTERNATIONAL JOURNAL OF NEUROSCIENCE.; Año: 2010 vol. 120 p. 11 - 16

SANTIAGO PEREZ-LLORET; MALCO ROSSI; DANIEL P. CARDINALI; MARCELO MERELLO

Actigraphic evaluation of motor fluctuations in patients with Parkinson's disease.

THE INTERNATIONAL JOURNAL OF NEUROSCIENCE.; Año: 2010 vol. 120 p. 137 - 143

SANTIAGO PEREZ-LLORET; EMMANUELLE BONDON-GUITTON; OLIVIER RASCOL; JEAN-LOUIS MONTASTRUC

Adverse drug reactions to dopamine agonists: a comparative study in the French Pharmacovigilance Database.

MOVEMENT DISORDERS; Año: 2010 vol. 25 p. 1876 - 1880

SANTIAGO PEREZ-LLORET; OLIVIER RASCOL

Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease.

EXPERT OPINION ON PHARMACOTHERAPY; Año: 2010 vol. 11 p. 2221 - 2230

DANIEL E. VIGO; SANTIAGO PEREZ LLORET; ALEJANDRO J. VIDELA; DANIEL PEREZ-CHADA; HORACIO M. HÜNICKEN; JORGE MERCURI; RAMÓN ROMERO; LEONARDO C. NICOLA SIRI; DANIEL CARDINALI

Heart rate nonlinear dynamics during sudden hypoxia at 8230 m simulated altitude.

Wilderness Environ Med; Año: 2010 vol. 21 p. 4 - 10

EXECUTIVE STUDY GROUP; SANTIAGO PEREZ-LLORET

Parkinson's disease dementia can be easily detected in routine clinical practice.

MOVEMENT DISORDERS; Año: 2010 vol. 25 p. 2769 - 2776

SANTIAGO PEREZ-LLORET

Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease.

CNS DRUGS; Año: 2010 vol. 24 p. 941 - 968

MARCO AURELIO REYES; SANTIAGO PEREZ-LLORET; ELIANA ROLDÁN GERSCOVICH; MARIA EUGENIA MARTIN; RAMÓN LEIGUARDA; MARCELO MERELLO

Addenbrooke's Cognitive Examination validation in Parkinson's disease.

EUROPEAN JOURNAL OF NEUROLOGY; Año: 2009 vol. 16 p. 142 - 147

OLIVIER RASCOL; SANTIAGO PEREZ-LLORET

Rotigotine transdermal delivery for the treatment of Parkinson’s disease.

EXPERT OPINION ON PHARMACOTHERAPY; Año: 2009 vol. 10 p. 677 - 691

SANTIAGO PEREZ-LLORET; MALCO ROSSI; DANIEL CARDINALI; MARCELO MERELLO

Parkinson's disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients.

JOURNAL OF NEUROLOGY; Año: 2009 vol. 256 p. 1480 - 1484

MARCELO MERELLO; SOL CAVANAGH; SANTIAGO PEREZ-LLORET; ELIANA ROLDÁN GERSCOVICH; VERÓNICA BRUNO; EDUARDO TENCA; RAMÓN LEIGUARDA

Irritability, psychomotor agitation and progressive insomnia induced by bilateral stimulation of the area surrounding the dorsal subthalamic nucleus (zona incerta) in Parkinson's disease patients.

JOURNAL OF NEUROLOGY; Año: 2009 vol. 256 p. 2091 - 2093

SUSANA ESTEVEZ; SANTIAGO PEREZ-LLORET; MARCELO MERELLO

Does clinical intolerance to a diagnostic acute levodopa challenge differentiate multiple system atrophy from PD?

THE INTERNATIONAL JOURNAL OF NEUROSCIENCE.; Año: 2009 vol. 119 p. 2257 - 2261

DANIEL PEREZ-CHADA; CHRISTOPHER L. DRAKE; SANTIAGO PEREZ-LLORET; ALEJANDRO J. VIDELA; DANIEL CARDINALI

Brief review: diurnal rhythms, obesity and educational achievement in South american cultures.

THE INTERNATIONAL JOURNAL OF NEUROSCIENCE.; Año: 2009 vol. 119 p. 1091 - 1104

SANTIAGO PEREZ-LLORET; MARIELA AMAYA; MARCELO MERELLO

Pregabalin-induced parkinsonism: a case report.

CLINICAL NEUROPHARMACOLOGY; Año: 2009 vol. 32 p. 353 - 354

JOSÉ BONET; BRANCO MAUTNER; SORAYA KERBAGE; MARÍA FERNANDA BONET; SANTIAGO PEREZ LLORET

Vital exhaustion is significantly linked to acute coronary events in Argentine population.

Vertex; Año: 2009 vol. 20 p. 421 - 426

SANTAIGO PEREZ-LLORET

Rotigotine for the Treatment of Advanced Parkinson’s Disease

European neurological review; Año: 2009 vol. 4 p. 24 - 28

OLIVIER RASCOL; SANTIAGO PEREZ LLORET

Rotigotine transdermal delivery for the treatment of Parkinson's disease.

EXPERT OPINION ON PHARMACOTHERAPY; Año: 2009 vol. 10 p. 677 - 691

SANTIAGO PEREZ-LLORET; MARCELO RISK; DIEGO A. GOLOMBEK; DANIEL P. CARDINALI; RAMIRO SANCHEZ; AGUSTÍN RAMIREZ

Blunting of circadian rhythms and increased acrophase variability in asleep hypertensive subjects

Chronobiology Internacional; Año: 2008 vol. 25 p. 99 - 113

SANTIAGO PEREZ LLORET; MALCO ROSSI; DANIEL P. CARDINALI; MARCELO MERELLO

Validation of the sleep related items of the Non-motor Symptoms Questionnaire for Parkinson’s disease (NMSQuest)

PARKINSONISM & RELATED DISORDERS; Año: 2008 vol. 14 p. 641 - 645

MARCELO MERELLO; EDUARDO TENCA; SANTIAGO PEREZ-LLORET; MARÍA EUGENIA MARTN; VERÓNICA BRUNO; SOL CAVANAGH; JULIO ANTICO; RAMÓN LEIGUARDA; SANTIAGO PEREZ LLORET

Prospective randomized one year follow up comparison of bilateral subthalamotomy versus bilateral subthalamic stimulation and the combination of both in Parkinson’s disease patients: A pilot study

British Journal of Neurosurgery; Año: 2008 vol. 22 p. 415 - 421

SANTIAGO PEREZ LLORET; JORGE TOBLLI; DANIEL CARDINALI; JUAN CLAUDIO MALATESTE; JOSÉ MILEI

Nocturnal hypertension defined by fixed cut-off limits is a better predictor of left ventricular hypertrophy than non-dipping

INTERNATIONAL JOURNAL OF CARDIOLOGY; Año: 2008 vol. 127 p. 387 - 389

SANTIAGO PEREZ LLORET; GABRIEL PIRÁN ARCE; MALCO ROSSI; MARÍA LAURA CAIVANO NEMET; PAZ SALSAMENDI; MARCELO MERELLO

Validation of a new scale for the evaluation of sialorrhea in Patients with Parkinson’s Disease

MOVEMENT DISORDERS; Año: 2007 vol. 22 p. 107 - 111

DANIEL PEREZ-CHADA; SANTIAGO PEREZ LLORET; ALEJANDRO J. VIDELA; DANIEL CARDINALI; MIGUEL A. BERGNA; MARIANO FERNÁNDEZACQUIER; LUIS LARRATEGUY; GUSTAVO E. ZABERT; CHRISTOPHER DRAKE

Sleep disordered breathing and daytime sleepiness are associated with poor academic performance in teenagers. A study using the pediatric daytime sleepiness scale (PDSS)

SLEEP.; Año: 2007 vol. 30 p. 1698 - 1703

MARCELO MERELLO; SANTIAGO PEREZ LLORET; JULIO ANTICO; JOSÉ A. OBESO

Dyskinesias induced by Subthalamotomy in Parkinson’s disease are unresponsive to Amantadine

JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY; Año: 2006 vol. 77 p. 172 - 174

HUGO BOQUETE; GABRIEL FIDELEFF; LILIANA ALBORNOZ; SANTIAGO PEREZ LLORET; MARTHA SUAREZ; ANA I. ESQUIFINO; MARGARITA HONFI; DANIEL P. CARDINALI

Gender-related differences in urinary 6-sulfatoxymelatonin levels in obese pubertal individuals.

JOURNAL OF PINEAL RESEARCH; Año: 2006 vol. 40 p. 214 - 218

SANTIAGO PEREZ-LLORET; JORGE E. TOBLLI; DANIEL E. VIGO; DANIEL P. CARDINALI; JOSÉ MILEI

Infradian awake and asleep systolic and diastolic blood pressure rhythms in humans

JOURNAL OF HYPERTENSION; Año: 2006 vol. 24 p. 1273 - 1279

SANTIAGO PEREZ-LLORET

Tratamiento Quirúrgico de la Enfermedad de Parkinson.

REVISTA NEUROLOGICA ARGENTINA (ED. IMPRESA); Año: 2006 vol. 31 p. 123 - 128

VERÓNICA BRUNO; PABLO SCACCHI; SANTIAGO PEREZ LLORET; ANA ESQUIFINO; DANIEL CARDINALI; RODOLFO CUTRERA

Melatonin treatment counteracts the hyperthermyc effect of Lipopolysaccharide injection in the Syrian Hamster

NEUROSCIENCE LETTERS; Año: 2005 vol. 389 p. 169 - 172

SANTIAGO PEREZ LLORET; ALEJANDRO GARCÍA AGUIRRE; DANIEL P. CARDINALI; JORGE E. TOBLLI

Disruption of ultradian and circadian rhythms of blood pressure in nondipper hypertensive patients

HYPERTENSION; Año: 2004 vol. 44 p. 311 - 315

BOGGIO VI; CASTRILLÓN PO; RICCIO P; PEREZ LLORET S; ESQUIFINO AI; CARDINALI DP; CUTRERA RA

Cerebroventriular Administration of Interferon-gamma modifies locomotor activity in the Golden Hamster

Neurosignals; Año: 2003 vol. 12 p. 89 - 94

MARGARITA BLANCO; NORBERTO KRIGUER; SANTIAGO PÉREZ LLORET; DANIEL P. CARDINALI

Attitudes towards treatment among patients suffering from sleep disorders. A Latin American survey

BMC Family Practice; Año: 2003 vol. 4 p. 17 - 23

LUIS GIROTTI; MANUEL LAGO; OSCAR IANOVSKY; MARCELO V. ELIZARI; ANDRÉS DINI; SANTIAGO PÉREZ LLORET; LILIANA E. ALBORNOZ; DANIEL P. CARDINALI

Low urinary 6-Sulphatoximelatonin levels in patients with severe congestive heart failure

ENDOCRINE; Año: 2003 vol. 22 p. 245 - 248

FURIO AM; CUTRERA RA; CASTILLO THEA V; PÉREZ LLORET S; RICCIO P; CACCURI RL; BRUSCO LI; CARDINALI DP

Effect of Melatonin on Changes in Locomotor Activity Rhythm of Syrian Hamsters Injected With Beta Amyloid Peptide 25–35 in the Suprachiasmatic Nuclei

CELLULAR AND MOLECULAR NEUROBIOLOGY.; Año: 2002 vol. 22 p. 699 - 709

CARDINALI DP; BORTMAN GP; LIOTTA G; PÉREZ LLORET S; ALBORNOZ LE; CUTRERA RA; BATISTA J; ORTEGA GALLO P

A Multifactorial Approach Employing Melatonin to Accelerate Resynchronization of Sleep-Wake Cycle After a 12 Time-Zone Transmeridian Flight in Elite Soccer Athletes

JOURNAL OF PINEAL RESEARCH; Año: 2002 vol. 32 p. 41 - 46

CARDINALI DP; BRUSCO LI; PÉREZ LLORET S; FURIO A

Melatonin in Sleep Disorders and Jet-lag

Neuroendocrinology Letters; Año: 2002 vol. 23 p. 9 - 13

CARDINALI DP; GVOZDENOVICH E; KAPLAN MR; FAINSTEIN I; SHIFIS HA; PÉREZ LLORET S; ALBORNOZ L; NEGRI A

A double blind placebo controlled study on melatonin efficacy to reduce anxiolityc benzodiazepine use in the elderly

Neuroendocrinology Letters; Año: 2002 vol. 23 p. 55 - 61